- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07654543
Dry Cupping Therapy and Muscle Energy Technique on Upper Crossed Syndrome
Effect of Combined Dry Cupping Therapy and Muscle Energy Technique on Upper Crossed Syndrome Patients. A Randomized Control Study
Visão geral do estudo
Status
Descrição detalhada
This study evaluated and compared the therapeutic efficacy of combining Dry Cupping therapy with the Muscle Energy Technique (MET) against each intervention applied independently, focusing on three core parameters: Neck Disability Index (NDI), Craniovertebral Angle (CVA), and Sagittal Shoulder-C7 Angle (SSA).
Methods: A pre-test post-test double-blinded randomized controlled trial design was employed. Seventy-six adults (aged 20-40 years) diagnosed with UCS were randomly allocated into four equal experimental groups (n = 19 per group): Group A received combined dry cupping and MET with conventional therapy; Group B received dry cupping with conventional therapy; Group C received MET with conventional therapy; and Group D received conventional therapy alone. Interventions were conducted over an 8-week period. Primary outcomes included functional impairment via the Arabic version of the NDI, and objective sagittal alignment parameters (CVA and SSA) measured using precision photometry via the Kinovea software application.
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
-
Giza, Egito
- Cairo University
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
Aceita Voluntários Saudáveis
Descrição
Inclusion Criteria:
- Participant inclusion was restricted to individuals between 20 and 40 years of age.
- The exact diagnostic criteria required a baseline craniovertebral angle (CVA) of less than 48 degrees.
- a sagittal shoulder-C7 angle (SSA) of less than 52 degrees.
Exclusion Criteria:
- acute post-surgical conditions
- structural spinal deformities (e.g., severe fixed structural scoliosis)
- cervical radiculopathy, or localized dermal infections contradicting cupping application.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Group A (Combined group)
Group A (Combined group): This group of nineteen subjects received combined dry cupping therapy, Muscle energy techniques, and conventional physical therapy.
|
19 subjects received combined dry cupping therapy, Muscle energy technique, and conventional physical therapy for eight weeks.
|
|
Experimental: Group B (Cupping group)
Group B (Cupping group): This group of nineteen subjects received dry cupping therapy and conventional physical therapy.
|
19 subjects received combined dry cupping therapy and conventional physical therapy for eight weeks.
|
|
Experimental: Group C (MET group)
Group C (MET group): This group of nineteen subjects received Muscle energy techniques and conventional physical therapy.
|
19 subjects received combined Muscle energy technique, and conventional physical therapy for eight weeks.
|
|
Comparador Ativo: Group D (Control group)
Group D (Control group): This group of nineteen subjects received conventional physical therapy alone
|
19 subjects received only conventional physical therapy for eight weeks.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Neck Disability Index (NDI)
Prazo: At baseline and re assessed following 8 weeks
|
Perceived functional limitations resulting from regional impairment were measured using the validated Arabic version of the NDI questionnaire.
This instrument evaluates 10 clinical sections (including activities of daily living, concentration, and pain profiles) scored from 0 to 5 per item, yielding a cumulative score out of 50.
Higher aggregate indices represent greater functional disability.
|
At baseline and re assessed following 8 weeks
|
|
craniovertebral angle (CVA)
Prazo: At baseline and re assessed following 8 weeks
|
This biomechanical index reflects the architectural severity of forward head posture.
It is defined as the angle formed between a horizontal line drawn through the spinous process of C7 and an intersecting line extending from the tragus of the ear to the C7 landmark.
CVA was measured using precision digital photogrammetry via the Kinovea software application.
|
At baseline and re assessed following 8 weeks
|
|
Sagittal Shoulder-C7 Angle (SSA)
Prazo: At baseline and re assessed following 8 weeks
|
This geometric marker quantifies shoulder roundedness and anterior protraction.
It is formed by the intersection of a horizontal reference line passing through the lateral aspect of the acromion with a line drawn from the C7 spinous process to the lateral acromion.
SSA was measured using precision digital photogrammetry via the Kinovea software application.
|
At baseline and re assessed following 8 weeks
|
Colaboradores e Investigadores
Patrocinador
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 012/006489
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .